Bioverge
Overview
Bioverge is an investment platform specializing in innovative healthcare startups. Their highly curated investment opportunities include emerging healthcare companies, operating at the convergence of biology and technology. Founded in 2016, it is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life. Bioverge offers a unique opportunity for investors. Investing once means that, as a shareholder, you’ll benefit financially from every investment they make, and every fund they manage. Their syndication model aggregates accredited investors into a Special Purpose Vehicle (SPV), which then invests directly in a single company or in multiple companies through one of their Access Funds or Thematic Funds. Bioverge has built a portfolio of 29 companies and has participated in 11 follow-on rounds for its portfolio companies, many of which are supported by some of the world's top-performing venture capital firms. Key among the company's offerings is access to the Bioverge Network, a consortium of functional specialists capable of supporting scientific and technical founders alongside experts to source and conduct diligence on new investment opportunities.
Investment Focus
- Accredited investors
- Compliance with SEC's Regulation D, Rule 506
- Adherence to regulations of respective jurisdictions
Portfolio Companies
Get the full list of 54,000+ investors
Bioverge and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Bioverge
What sectors does Bioverge invest in?
Bioverge invests in Healthcare, Life Sciences, Healthcare Services, Digital Health, Pharmaceuticals and Medical Devices, and is based in San Francisco, California, United States. Bioverge is listed as a venture capital in the ConnectSafely investor database.
What stage does Bioverge invest at?
Bioverge backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 5K - 500K.
Which regions does Bioverge invest in?
Bioverge invests across United States.
Who are the partners at Bioverge?
Team members listed for Bioverge include Rick Gibb (Co-Founder / Investment Partner / COO).
What companies has Bioverge invested in?
Bioverge's portfolio includes Enveda Biosciences, Notable Labs, Alto Neuroscience, Contraline, Elucid, OccamzRazor, Aspen Neuroscience and Bionaut Labs.
How do I contact Bioverge?
Bioverge's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
